NEPH — Nephros, Inc.

Nephros, Inc. Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Revenue: Achieved a record $5.2 million, a 7% increase from $4.9 million in Q1 2025, marking the first time revenue exceeded $5 million in a single quarter.
• Gross Margin: Declined to 57% from 65% year-over-year, attributed to tariffs ($200,000 impact), currency pressures (strengthening euro), and a shift in product mix towards lower-margin commercial applications.
• Net Income: Decreased by 75% to approximately $140,000 compared to $558,000 in the prior year.
• Adjusted EBITDA: Fell 69% to approximately $206,000 from $667,000 in Q1 2025.
• Cash Position: Approximately $4 million in cash, with the company remaining debt-free.

2. Strategic Updates and Business Highlights

• Programmatic Revenue Growth: Strong performance in programmatic business, with a 23% year-over-year increase, indicating successful customer installations and reorder rates.
• Expansion into Commercial Applications: Intentional strategy to penetrate larger markets such as ice machines, drinking fountains, and other high-use water applications, despite lower margins.
• Service and Installation Programs: Strengthening recurring revenue through installation and replacement services, enhancing customer relationships.
• Education Initiatives: Launch of the Nephros Water Institute to position the company earlier in the customer decision-making process.

3. Forward Guidance and Outlook

• Growth Expectations: Management remains confident in continued revenue growth driven by market expansion in New York and Puerto Rico, along with increasing adoption of products and services.
• Margin Improvement: Anticipated improvement in gross margins as new inventory reflects reduced tariff rates and as the company implements mitigation strategies.

4. Bad News, Challenges, or Points of Concern

• Margin Pressure: The decline in gross margin is a concern, driven by external cost pressures and a strategic shift towards lower-margin commercial products.
• Emergency Response Revenue Decline: Notable decrease in emergency response revenue compared to a high prior year quarter, which may indicate volatility in this segment.
• Competitive Pressures: Increased competition in lower-end markets and challenges in differentiating products in non-regulated environments like hospitality and municipal sectors.

5. Notable Q&A Insights

• Certification for Water Management: The company is in the early stages of rolling out certification services, with plans to expand this offering to smaller healthcare entities.
• Focus on New York Market: A dedicated sales leader has been hired to focus on the New York City area, which has a high density of hospitals and a pressing need for infection control solutions.
• Active Customer Sites: Increased to 1,676, indicating healthy growth in customer engagement and revenue per customer.
• Regulatory Impact: Management sees potential benefits from upcoming EPA regulations on PFAS and microplastics, although current market conditions limit immediate demand.
• Home Market Potential: Discussion of potential expansion into the home water filtration market, with plans to explore partnerships rather than direct entry.

Overall, Nephros reported a strong quarter with record revenues but faced challenges with margin pressures and competitive dynamics as it expands into new markets. The company remains optimistic about future growth and strategic initiatives.